Skip to content
healthcare.dev

Loratadine and Pseudoephedrine Sulfate

NDC 21130-724, Loratadine and Pseudoephedrine Sulfate, tablet, film coated, extended release, from Safeway Inc..

Product NDC
21130-724
Status
Listed
Labeler
Safeway Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA076557
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/21130-724 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
  • PSEUDOEPHEDRINE SULFATE240 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
21130-724-152113007241515 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (21130-724-15)
21130-724-692113007246910 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (21130-724-69)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 21130-724 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/21130-724 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 21130-724. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.